| Title | Author(s) | Year | View Count |  | Do common in silico tools predict the clinical consequences of amino-acid substitutions in the CFTR gene? | Dorfman, R; Nalpathamkalam, T; Taylor, C; Gonska, T; Keenan, K; Yuan, XW; Corey, M; Tsui, LC; Zielenski, J; Durie, P | 2010 | 44 |
 | Modifier gene study of meconium ileus in cystic fibrosis: Statistical considerations and gene mapping results | Dorfman, R; Li, W; Sun, L; Lin, F; Wang, Y; Sandford, A; Paré, PD; McKay, K; Kayserova, H; Piskackova, T; MacEk, M; Czerska, K; Sands, D; Tiddens, H; Margarit, S; Repetto, G; Sontag, MK; Accurso, FJ; Blackman, S; Cutting, GR; Tsui, LC; Corey, M; Durie, P; Zielenski, J; Strug, LJ | 2009 | 130 |
 | Complex two-gene modulation of lung disease severity in children with cystic fibrosis | Dorfman, R; Sandford, A; Taylor, C; Huang, B; Frangolias, D; Wang, Y; Sang, R; Pereira, L; Sun, L; Berthiaume, Y; Tsui, LC; Paré, PD; Durie, P; Corey, M; Zielenski, J | 2008 | 159 |
 | Mutations in the cystic fibrosis transmembrane regulator gene and in vivo transepithelial potentials | Wilschanski, M; Dupuis, A; Ellis, L; Jarvi, K; Zielenski, J; Tullis, E; Martin, S; Corey, M; Tsui, LC; Durie, P | 2006 | 1,412 |
 | The cystic fibrosis transmembrane conductance regulator gene and ion channel function in patients with idiopathic pancreatitis | Bishop, MD; Freedman, SD; Zielenski, J; Ahmed, N; Dupuis, A; Martin, S; Ellis, L; Shea, J; Hopper, I; Corey, M; Kortan, P; Haber, G; Ross, C; Tzountzouris, J; Steele, L; Ray, PN; Tsui, LC; Durie, PR | 2005 | 845 |
 | The prevalence and clinical characteristics of cystic fibrosis in South Asian Canadian immigrants | MeiZahav, M; Durie, P; Zielenski, J; Solomon, M; Tullis, E; Tsui, LC; Corey, M | 2005 | 858 |
 | Locus CFM1: a potential modifier of pancreatic disease in children with cystic fibrosis | Sontag, MK; Hokanson, JE; Marshall, JA; Corey, M; Zerbe, GO; Tsui, L-C; Zielenski, J; Accurso, FJ | 2003 | 280 |
 | Glucose intolerance in children with cystic fibrosis | Solomon, MP; Wilson, DC; Corey, M; Kalnins, D; Zielenski, J; Tsui, LC; Pencharz, P; Durie, P; Sweezey, NB | 2003 | 430 |
 | Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas | Ahmed, N; Corey, M; Forstner, G; Zielenski, J; Tsui, LC; Ellis, L; Tullis, E; Durie, P | 2003 | 352 |
 | Genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis | Durno, C; Corey, M; Zielenski, J; Tullis, E; Tsui, LC; Durie, P | 2002 | 182 |
 | Detection of modifier loci influencing the lung phenotype of cystic fibrosis knockout mice | Haston, CK; McKerlie, C; Newbigging, S; Corey, M; Rozmahel, R; Tsui, LC | 2002 | 228 |
 | Mapping of genetic factors influencing the weight of cystic fibrosis knockout mice | Haston, CK; Corey, M; Tsui, LC | 2002 | 232 |
 | CFTR gene mutations and the pancreatic phenotype | Durie, PR; Ahmed, N; Corey, M; Zielenski, J; Ellis, L; Tullis, E; Tsui, LC | 1999 | 121 |
 | Detection of a cystic fibrosis modifier locus for meconium ileus on human chromosome 19q13 [3] | Zielenski, J; Corey, M; Rozmahel, R; Markiewicz, D; Aznarez, I; Casals, T; Larriba, S; Mercier, B; Cutting, GR; Krebsova, A; Macek M, Jr; Langfelder Schwind, E; Marshall, BC; DecelieGermana, J; Claustres, M; Palacio, A; Bal, J; Nowakowska, A; Ferec, C; Estivill, X; Durie, P; Tsui, LC | 1999 | 130 |
 | Uncertainty in the diagnosis of cystic fibrosis: Possible role of in vivo nasal potential difference measurements | Wilson, DC; Ellis, L; Zielenski, J; Corey, M; Ip, WF; Tsui, LC; Tullis, E; Knowles, MR; Durie, PR | 1998 | 309 |
 | Genotype/phenotype in relation to lung disease | Durie, PR; Tullis, E; Corey, M; Ellis, L; Martin, S; Jarvi, K; Zielenski, J; Gilljam, M; Tsui, LC | 1998 | 97 |
 | Defining the modifiers of CF pathophysiology | Rozmahel, R; Nguyen, V; Corey, M; Haston, CK; Kent, G; Bear, C; Durie, P; Tsui, LC | 1998 | 96 |
 | Identification of six mutations (R31L, 441delA, 681delC, 1461ins4, W1089R, E1104X) in the cystic fibrosis transmembrane conductance regulator (CFTR) gene | Zielenski, J; Markiewicz, D; Chen, HS; Schappert, K; Seller, A; Durie, P; Corey, M; Tsui, LC | 1995 | 276 |
 | Correlation of sweat chloride concentration with classes of the cystic fibrosis transmembrane conductance regulator gene mutations | Wilschanski, M; Zielenski, J; Markiewicz, D; Tsui, LC; Corey, M; Levison, H; Durie, PR | 1995 | 259 |
 | CFTR gene variant for patients with congenital absence of vas deferens [3] | Zielenski, J; Patrizio, P; Corey, M; Handelin, B; Markiewicz, D; Asch, R; Tsui, LC | 1995 | 262 |
|